Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial) (EADO)

This study has been completed.
Sponsor:
Collaborator:
Schering-Plough
Information provided by:
University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT00221702
First received: September 13, 2005
Last updated: October 12, 2010
Last verified: October 2010